Lusty lads looking to lock lips with Caroline Cray Quinn better be careful because a smooch could prove fatal. The ...

Patients with chronic spontaneous urticaria improved early, with benefits lasting through the 52-week follow-up for those who ...

Every year, on October 1st, is World Urticaria Day, a day dedicated to raising awareness about urticaria, commonly known as ...

Goldman Sachs initiates Celldex Therapeutics 9CDLX) at neutral, citing concerns about market opportunity and lack of near-term catalysts. Read more here.

Richard Law CFA, an analyst from Goldman Sachs, has initiated a new Hold rating on Celldex (CLDX). Richard Law CFA has given his Hold rating ...

(150 mg Q4W) achieved complete response at Week 52 -- Rapid, profound and durable improvement in UAS7 as early as Week 1 with a deepening of response over 52 weeks -- Robust improvement across ...

Approval follows EU approval of Dupixent for adults with COPD with raised blood eosinophils, and is based on two landmark Phase 3 trials showing ...

My battle with fibromyalgia, a chronic pain condition, began when I was in my second year at Nanyang Technological University ...

Today's health news includes new research on Ozempic and drug overdose risk and on using MRIs to diagnose prostate cancer.

Celldex stock falls due to safety concerns related to the treatment of urticaria patients with barzolvolimab in a phase II study, despite robust efficacy data.